Literature DB >> 22451301

Mouse models of spinocerebellar ataxia type 3 (Machado-Joseph disease).

Veronica F Colomer Gould1.   

Abstract

Machado-Joseph disease, also called spinocerebellar ataxia type 3 (MJD/SCA3), is a hereditary and neurodegenerative movement disorder caused by ataxin-3 with a pathological polyglutamine stretch (mutant ataxin-3). Seven transgenic mouse models expressing full-length human mutant ataxin-3 throughout the brain have been generated and are compared in this review. They vary in the corresponding transgenic DNA constructs with differences that include the encoded human ataxin-3 isoform(s), number of polyglutamine(s), and the promoter driving transgene expression. The behaviors/signs evaluated in most models are body weight, balance/coordination, locomotor activity, gait, limb position, and age at death. The pathology analyzed includes presence of neuronal intranuclear inclusions, and qualitative evidence of neurodegeneration. On the basis of striking similarities in age-range of detection and number of behavior/sign abnormalities and pathology, all but 1 mouse model could be readily sorted into groups with high, intermediate, and low severity of phenotype. Stereological analysis of neurodegeneration was performed in the same brain regions in 2 mouse models; the corresponding results are consistent with the classification of the mouse models.

Entities:  

Mesh:

Year:  2012        PMID: 22451301      PMCID: PMC3337014          DOI: 10.1007/s13311-012-0117-x

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  53 in total

Review 1.  Machado-Joseph Disease: from first descriptions to new perspectives.

Authors:  Conceição Bettencourt; Manuela Lima
Journal:  Orphanet J Rare Dis       Date:  2011-06-02       Impact factor: 4.123

2.  Azorean disease of the nervous system.

Authors:  F C Romanul; H L Fowler; J Radvany; R G Feldman; M Feingold
Journal:  N Engl J Med       Date:  1977-06-30       Impact factor: 91.245

3.  Autosomal dominant striatonigral degeneration. A clinical, pathologic, and biochemical study of a new genetic disorder.

Authors:  R N Rosenberg; W L Nyhan; C Bay; P Shore
Journal:  Neurology       Date:  1976-08       Impact factor: 9.910

4.  Machado disease. A hereditary ataxia in Portuguese emigrants to Massachusetts.

Authors:  K K Nakano; D M Dawson; A Spence
Journal:  Neurology       Date:  1972-01       Impact factor: 9.910

5.  Clinical criteria for diagnosis of Machado-Joseph disease: report of a non-Azorena Portuguese family.

Authors:  L Lima; P Coutinho
Journal:  Neurology       Date:  1980-03       Impact factor: 9.910

6.  Presumably Azorean disease in a presumably non-Portuguese family.

Authors:  E B Healton; J C Brust; D L Kerr; S Resor; A Penn
Journal:  Neurology       Date:  1980-10       Impact factor: 9.910

7.  Joseph's disease: an autosomal dominant neurological disease in the Portuguese of the United States and the Azores Islands.

Authors:  R N Rosenberg; W L Nyhan; P Coutinho; C Bay
Journal:  Adv Neurol       Date:  1978

8.  The natural history of Machado-Joseph disease. An analysis of 138 personally examined cases.

Authors:  A Barbeau; M Roy; L Cunha; A N de Vincente; R N Rosenberg; W L Nyhan; P L MacLeod; G Chazot; L B Langston; D M Dawson
Journal:  Can J Neurol Sci       Date:  1984-11       Impact factor: 2.104

9.  Machado-Joseph-Azorean disease. A ten-year study.

Authors:  H L Fowler
Journal:  Arch Neurol       Date:  1984-09

10.  Autosomal dominant system degeneration in Portuguese families of the Azores Islands. A new genetic disorder involving cerebellar, pyramidal, extrapyramidal and spinal cord motor functions.

Authors:  P Coutinho; C Andrade
Journal:  Neurology       Date:  1978-07       Impact factor: 9.910

View more
  13 in total

1.  Animal models of neurological disorders.

Authors:  Marie-Francoise Chesselet; S Thomas Carmichael
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

2.  Calpain Inhibition Is Protective in Machado-Joseph Disease Zebrafish Due to Induction of Autophagy.

Authors:  Maxinne Watchon; Kristy C Yuan; Nick Mackovski; Adam J Svahn; Nicholas J Cole; Claire Goldsbury; Silke Rinkwitz; Thomas S Becker; Garth A Nicholson; Angela S Laird
Journal:  J Neurosci       Date:  2017-07-07       Impact factor: 6.167

3.  A knockin mouse model of spinocerebellar ataxia type 3 exhibits prominent aggregate pathology and aberrant splicing of the disease gene transcript.

Authors:  Biswarathan Ramani; Ginny M Harris; Rogerio Huang; Takahiro Seki; Geoffrey G Murphy; Maria do Carmo Costa; Svetlana Fischer; Thomas L Saunders; Guangbin Xia; Richard C McEachin; Henry L Paulson
Journal:  Hum Mol Genet       Date:  2014-10-15       Impact factor: 6.150

4.  Consensus Paper: Strengths and Weaknesses of Animal Models of Spinocerebellar Ataxias and Their Clinical Implications.

Authors:  Jan Cendelin; Marija Cvetanovic; Mandi Gandelman; Hirokazu Hirai; Harry T Orr; Stefan M Pulst; Michael Strupp; Filip Tichanek; Jan Tuma; Mario Manto
Journal:  Cerebellum       Date:  2021-08-10       Impact factor: 3.648

5.  Comparison of spinocerebellar ataxia type 3 mouse models identifies early gain-of-function, cell-autonomous transcriptional changes in oligodendrocytes.

Authors:  Biswarathan Ramani; Bharat Panwar; Lauren R Moore; Bo Wang; Rogerio Huang; Yuanfang Guan; Henry L Paulson
Journal:  Hum Mol Genet       Date:  2017-09-01       Impact factor: 6.150

6.  Karyopherin α-3 is a key protein in the pathogenesis of spinocerebellar ataxia type 3 controlling the nuclear localization of ataxin-3.

Authors:  Anna Sergeevna Sowa; Elodie Martin; Inês Morgado Martins; Jana Schmidt; Reinhard Depping; Jonasz Jeremiasz Weber; Franziska Rother; Enno Hartmann; Michael Bader; Olaf Riess; Hervé Tricoire; Thorsten Schmidt
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-23       Impact factor: 11.205

Review 7.  Integration of modeling with experimental and clinical findings synthesizes and refines the central role of inositol 1,4,5-trisphosphate receptor 1 in spinocerebellar ataxia.

Authors:  Sherry-Ann Brown; Leslie M Loew
Journal:  Front Neurosci       Date:  2015-01-21       Impact factor: 4.677

8.  Computational neurobiology is a useful tool in translational neurology: the example of ataxia.

Authors:  Sherry-Ann Brown; Louise D McCullough; Leslie M Loew
Journal:  Front Neurosci       Date:  2015-01-21       Impact factor: 4.677

Review 9.  Endocannabinoid System in Spinocerebellar Ataxia Type-3 and Other Autosomal-Dominant Cerebellar Ataxias: Potential Role in Pathogenesis and Expected Relevance as Neuroprotective Targets.

Authors:  María Gómez-Ruiz; Carmen Rodríguez-Cueto; Eva Luna-Piñel; Mariluz Hernández-Gálvez; Javier Fernández-Ruiz
Journal:  Front Mol Neurosci       Date:  2019-04-24       Impact factor: 5.639

10.  Parkinson-like phenotype in insulin-resistant PED/PEA-15 transgenic mice.

Authors:  Giuseppe Perruolo; Davide Viggiano; Francesca Fiory; Angela Cassese; Cecilia Nigro; Antonietta Liotti; Claudia Miele; Francesco Beguinot; Pietro Formisano
Journal:  Sci Rep       Date:  2016-07-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.